Trials / Conditions / Recurrent Childhood Central Nervous System Embryonal Tumor

Recurrent Childhood Central Nervous System Embryonal Tumor

6 registered clinical trials studyying Recurrent Childhood Central Nervous System Embryonal Tumor.

Status	Trial	Sponsor	Phase
Terminated	Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS T NCT01088763	National Cancer Institute (NCI)	Phase 1
Completed	Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spi NCT01076530	National Cancer Institute (NCI)	Phase 1
Completed	Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Cent NCT00994500	National Cancer Institute (NCI)	Phase 1
Completed	Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Tr NCT00929903	National Cancer Institute (NCI)	Phase 1
Completed	Sunitinib in Treating Young Patients With Refractory Solid Tumors NCT00387920	National Cancer Institute (NCI)	Phase 1
Completed	Combination Chemotherapy in Treating Young Patients With Advanced Solid Tumors NCT00281944	National Cancer Institute (NCI)	Phase 1